Immunohistological analyses of myocardial infiltrating cells in various animal models of myocarditis

Experimental and Clinical Cardiology

Volumn 8, Issue 1, 2003, Pages 13-16

  Yuan, Zuyi ^a   Shioji, Keisuke ^a   Kishimoto, Chiharu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Animal model; Giant cell myocarditis; Viral myocarditis

Indexed keywords

HEART ANTIGEN; MYOSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELL INFILTRATION; CONTROLLED STUDY; COXSACKIE VIRUS; DENDRITIC CELL; DISEASE SEVERITY; GIANT CELL; HEART MUSCLE CELL; HEART MUSCLE INJURY; IMMUNOHISTOLOGY; IMMUNOLOGICAL PARAMETERS; MACROPHAGE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; MYOCARDITIS; NONHUMAN; PATHOLOGY; QUANTITATIVE ANALYSIS; RAT; T LYMPHOCYTE; VIRUS MYOCARDITIS;

EID: 0141869876     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Kawai C. From myocarditis to cardiomyopathy: Mechanisms of inflammation and cell death. Circulation 1999;99:1091-100.
2. Reyes M, Lerner AM. Coxsackievirus myocarditis - With special reference to acute and chronic effects. Prog Cardiovasc Dis 1985;27:373-94.
3. Kishimoto C, Misaki T, Crumpacker CS, Abelmann WH. Serial immunological identification of lymphocyte subsets in murine coxsackievirus B3 myocarditis: Different kinetics and significance of lymphocyte subsets in heart and in peripheral blood. Circulation 1988;77:645-53.
4. Neu N, Ploier B, Öfner C. Cardiac myosin-induced myocarditis: Heart autoantibodies are not involved in the induction of the disease. J Immunol 1990;145:4094-100.
5. Kodama M, Matsumoto Y, Fujiwara M, Masani F, Izumi T, Sibata A. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol 1990;57:250-62.
6. Neu N, Klieber R, Fruhwirth M, Berger P. Cardiac myosin-induced myocarditis as a model of postinfectious autoimmunity. Eur Heart J 1991;12(Suppl D):117-20.
7. Shioji K, Kishimoto C, Nakayama Y, Sasayama S. Strain difference in rats with experimental giant cell myocarditis. Jpn Circ J 2000;64:283-6.
8. Malkiei S, Factor S, Diamond B. Autoimmune myocarditis does not require B cells for antigen presentation. J Immunol 1999;163:5265-8.
9. Opavsky MA, Penninger J, Aitken K, et al. Susceptibility to myocarditis is dependent on the response of αβ T lymphocytes to coxsackieviral infection. Circ Res 1999;85:551-8.
10. Bachmaier K, Neu N, Yeung RS, Mak TW, Liu P, Penninger JM. Generation of humanized mice susceptible to peptide-induced inflammatory heart disease. Circulation 1999;99:1885-91.
11. Hirono S, Islam MO, Nakazawa M, et al. Expression of inducible nitric oxide synthase in rat experimental autoimmune myocarditis with special reference to changes in cardiac hemodynamics. Circ Res 1997;80:11-5.
12. Kishimoto C, Kuroki Y, Hiraoka Y, Ochiai H, Kurokawa M, Sasayama S. Cytokine and murine coxsackievirus B3 myocarditis. Interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage. Circulation 1994;28:2836-42.
13. Shioji K, Kishimoto C, Nakamura H, et al. Upregulation of thioredoxin (TRX) expression in giant cell myocarditis in rats. FEBS Lett 2000;472:109-13.
14. Hiraoka Y, Kishimoto C, Takada H, et al. Role of oxygen derived free radicals in the pathogenesis of coxsackievirus B3 myocarditis in mice. Cardiovasc Res 1993;27:957-61.
15. Yuan Z, Kishimoto C, Shioji K, Nakamura H, Yodoi J, Sasayama S. Temocapril treatment ameliorates autoimmune myocarditis associated with enhanced cardiomyocyte thioredoxin expression. Cardiovasc Res 2002;55:320-8.